Officials Cast Doubt on a Dementia Drug, but Human Trials Continuenews2024-10-02T19:41:40+00:00October 2nd, 2024|The New York Times|
F.D.A. Approves a New Antipsychotic Drugnews2024-09-27T14:36:45+00:00September 27th, 2024|The New York Times|
F.T.C. Accuses Drug Middlemen of Inflating Insulin Pricesnews2024-09-20T19:16:14+00:00September 20th, 2024|The New York Times|
Kourtney Kardashian’s Weight Loss Supplement Claims to Work Like Ozempic. Does It?news2024-09-17T09:03:22+00:00September 17th, 2024|The New York Times|
Mushroom-Laced Candy Recall Highlights F.D.A.’s Limited Safety Rolenews2024-09-07T09:00:14+00:00September 7th, 2024|The New York Times|
Hot Summer Threatens Efficacy of Mail-Order Medicationsnews2024-08-13T14:04:23+00:00August 13th, 2024|The New York Times|
FDA Declines to Approve MDMA Therapy, and Seeks Further Studynews2024-08-10T11:56:53+00:00August 10th, 2024|The New York Times|
Veterans and Lawmakers Lobby for Approval of MDMA Therapynews2024-08-08T22:01:37+00:00August 8th, 2024|The New York Times|
F.T.C. Says Middlemen Seem to Drive Up Drug Pricesnews2024-07-09T12:49:06+00:00July 9th, 2024|The New York Times|
Aumentan a 80 las muertes relacionadas con un suplemento japonésnews2024-06-28T19:27:06+00:00June 28th, 2024|The New York Times|
